Home›Companies›Biotech & Pharma›ViruTech Systems

ViruTech Systems, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 5, 2023·Suggest an edit

About ViruTech Systems

ViruTech Systems is a private company based in Minneapolis, Minnesota, incorporated in 2020 in Delaware. It has reported $60,000 raised in two offerings on Form D since December 2020.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetDec 5, 2023$0of $7.5M target0—Equity, Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Nov 12, 2020Dec 1, 2020$60,000of $1.2M target1$60,000EquityRule 506(b)Form D ↗
Total, two offerings$60,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ViruTech Systems's Form D filed Dec 5, 2023.

LC
Lorraine Childs
VP Human Resources & Administration, director
RJ
Robert Jones
Director
AR
Alan Roth
Chief Financial Officer
RU
Robert Usselman
Chief Scientist
NP
Nancy Pearlman
VP Operations
TC
Timothy Childs
Chairman, President, Principal Technology Officer

Earlier filings also listed Robert Daly (executive officer, last listed Dec 2020) and Fred Stelter (executive officer, last listed Dec 2020).

Sources

  1. SECViruTech Systems, Inc. filing history